Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
about
Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
description
clinical trial
@en
klinisch onderzoek
@nl
name
Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
@en
type
label
Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
@en
prefLabel
Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
@en
P1476
Phase II Study of Osimertinib in NSCLC Patients With EGFR Exon 20 Insertion Mutation
@en
P3098
NCT03414814
P4844
P580
2018-01-04T00:00:00Z
P582
2022-06-15T00:00:00Z